Skip to content
Unrated Drug recall · FDA · Published December 5, 2012

West-Ward Recalls Prednisone 10mg Tablets Due to Foreign Substance

West-Ward recalls Prednisone 10mg tablets due to gray defects. Check your lot numbers and expiration dates for affected bottles distributed nationwide.

🇺🇸 FDA recall #D-149-2013DrugWest-Ward Pharmaceutical ›
Take action

Contact the company

Recalling firmWest-ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

West-Ward Pharmaceutical Corp. is recalling PredniSONE Tablets, USP, 10 mg because they contain gray defects, which are identified as a foreign substance. The recall affects specific lots of 100-count and 1000-count bottles distributed across the United States and Puerto Rico. The record does not specify what consumers should do with the affected medication or provide a remedy. Read more at govinfonow.com/recall/48461-west-ward-pharmaceutical-corp-recalls-prednisone-tablets-usp-10-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/48461-west-ward-pharmaceutical-corp-recalls-prednisone-tablets-usp-10-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-149-2013

Cite this page

“West-Ward Recalls Prednisone 10mg Tablets Due to Foreign Substance.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48461-west-ward-pharmaceutical-corp-recalls-prednisone-tablets-usp-10-mg. Based on FDA recall #D-149-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-149-2013%22&limit=1).

The FDA announced on Dec. 5, 2012, that West-Ward Pharmaceutical Corp. is recalling PredniSONE Tablets, USP, 10 mg, due to gray defects in the tablets. The recall affects 128,319 bottles distributed nationwide and in Puerto Rico.

How to tell if you have it

  • Brand: West-Ward Pharmaceutical
  • Product: PredniSONE Tablets, USP, 10 mg
  • NDC 0143-1473-01 (100-count bottles)
  • NDC 0143-1473-10 (1000-count bottles)
  • Lot codes: 69403A, 69403B (Exp 10/15); 69404A, 69405A, 69515A, 69702A, 69702B, 69703A (Exp 11/15); 69767A, 69767B (Exp 12/15)

The hazard

The tablets contain gray defects identified as a foreign substance. The FDA classified this Class II recall.

Context

GovInfoNow's records show West-Ward Pharmaceutical Corp. has 23 other recalls on record since April 13, 2012. Other recent recalls of similar products include Lupin prednisolone acetate ophthalmic suspension (June 4, 2026), Golden State Medical Primidone Tablets (April 27, 2026), and Golden State Baclofen Tablets (Nov. 26, 2025).

How to tell if you have this one

Check your bottle for the brand West-Ward Pharmaceutical Corp. and the NDC numbers 0143-1473-01 (100-count) or 0143-1473-10 (1000-count). Verify if your lot number is one of: 69403A, 69403B, 69404A, 69405A, 69515A, 69702A, 69702B, 69703A (Exp 10/15 or 11/15), or 69767A, 69767B (Exp 12/15).

  • Brand
    West-Ward Pharmaceutical
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.3 years after the firm started it.

1. Firm started the recall: Dec 5, 201212. FDA classified it Class II: Feb 5, 201323. Published in FDA’s Enforcement Report: Feb 13, 201334. FDA terminated the recall: Mar 18, 2015420122015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-149-2013 (December 5, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-149-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA